Drugs / Xuesaitong
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01615003 | May 2012 → Jul 2014 | intermediate coronary syndrome | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xuesaitong | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01615003 ↗ |
| Route | Oral | “once take two pills and twice a day during a month.” NCT01615003 ↗ |